Apr. 29 at 10:04 AM
Black Hawk (
$BKHA) announces merger with Vesicor at
$70M valuation. Deal requires
$10M PIPE financing and faces clinical development risks. SPAC's negative book value (-
$0.255/share) and cash burn remain concerns. Closing expected Q4 2025 if shareholders approve.
https://www.sec.gov/Archives/edgar/data/2000775/000182912625003009/blackhawk_8k.htm